| Record ID | harvard_bibliographic_metadata/ab.bib.13.20150123.full.mrc:864222302:1836 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.13.20150123.full.mrc:864222302:1836?format=raw |
LEADER: 01836cam a2200433 a 4500
001 013776565-7
005 20131004191220.0
008 090223s2009 dcua b 100 0 eng
010 $a 2009284679
016 7 $a101505853$2DNLM
020 $a9780309128674
020 $a0309128676
035 0 $aocn310392638
040 $aNLM$beng$cNLM$dYDXCP$dNRZ$dNTD$dBTCTA$dCDX$dIXA$dEEM$dDLC$dOCLCQ
042 $anlmcopyc
043 $an-us---
050 00 $aR853.C55$bM85 2009
060 00 $a2009 F-375
060 10 $aQV 771$bM9605 2009
082 04 $a610.724$222
245 00 $aMulti-center phase III clinical trials and NCI cooperative groups :$bworkshop summary /$cMargie Patlak, Sharyl Nass, and Christine Micheel, rapporteurs ; National Cancer Policy Forum, Institute of Medicine of the National Academies.
260 $aWashington, D.C. :$bNational Academies Press,$cc2009.
300 $axii, 121 p. :$bill. ;$c23 cm.
504 $aIncludes bibliographical references (p. 97-101).
505 0 $aOrganization of the NCI clinical trials system -- Lessons from non-cooperative group multi-center clinical trials -- Barriers to patient recruitment and physician participation -- Data collection standards and monitoring -- Costs of cooperative group clinical trials.
530 $aAlso available online.
610 20 $aNational Cancer Institute (U.S.)
650 0 $aCancer$xTreatment$zUnited States.
650 0 $aClinical trials.
650 12 $aClinical Trials, Phase III as Topic$zUnited States$vCongresses.
650 22 $aMulticenter Studies as Topic$zUnited States$vCongresses.
700 1 $aPatlak, Margie.
700 1 $aNass, Sharyl J.
700 1 $aMicheel, Christine.
710 2 $aNational Cancer Policy Forum (U.S.)
710 2 $aInstitute of Medicine (U.S.)
988 $a20130912
049 $aHMSS
906 $0OCLC